Key Insights on CD38 and BCMA as Targets for Therapy in Multiple Myeloma

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Targeting CD38 and BCMA in Myeloma: Evidence and Enhanced Outcomes With Innovative Therapies

Content Format:

Video

Credit Type:

AMA

Credits:

1.50
CD38-Targeted Antibodies in Transplant-Eligible and Transplant-Ineligible Patients With Myeloma

Content Format:

Slideset

Credit Type:

--

Credits:

--
Thinking Through Key Considerations for Emergency Medical Professionals on the Management of Patients With Myeloma Receiving CAR T-Cell Therapy or Bispecific Antibodies

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Critical Actions in Emergency Medicine: Timely Diagnosis and Treatment of CAR T-Cell‒ and Bispecific Antibody‒Related AEs in Multiple Myeloma

Content Format:

Slideset

Credit Type:

--

Credits:

--
New Treatments for RRMM: A Focus on Immunotherapy and Novel Approaches

Content Format:

Slideset

Credit Type:

--

Credits:

--
The Role of Bridging Therapeutic Strategies for Patients With Multiple Myeloma Receiving CAR T-Cell Therapy

Content Format:

Slideset

Credit Type:

--

Credits:

--